University of Sheffield and Pfizer dispatch new consortium to quicken improvement of ATMPs Kumar Jeetendra | November 24, 2020 The University of Sheffield and Pfizer have today (23 November 2020) established a new consortium which aims to standardize and accelerate the growth of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative remedies to reach patients sooner. The new, five-year consortium, Accelerating Research and Innovation for Advanced Therapies (ARDAT), is supported by the Innovative Medicines …
Patients’ own stem cells can be utilized to develop new bones, study shows Kumar Jeetendra | November 23, 2020 A new, groundbreaking study from the University of Bergen (UiB) shows that a patients’ own stem cells can be used to grow new bone. This can potentially help millions of people who are partially edentulous and have inadequate bone for placement of dental implants. The Maxibone Project, coordinated by Pierre Layrolle, Inserm, University of Nantes, …
AstraZeneca begins new COVID-19 anticipation preliminaries of antibody cocktail Kumar Jeetendra | November 21, 2020 AstraZeneca started late-stage trials on November 21 of an experimental long-acting monoclonal antibody combination drug it hopes could be utilised as a so-called prophylactic to prevent COVID-19 infection in at-risk individuals for up to 12 months. The Phase III global clinical trial will recruit a total of 5,000 people across countries in Europe and the …
Polypill in addition to headache medicine and polypill alone reduced cardiovascular sickness hazard Kumar Jeetendra | November 17, 2020 A single, daily pill combining blood pressure and cholesterol medications, as well as the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking study presented today in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions 2020. The virtual conference, …
Who will be the first to get COVID-19 antibodies? Kumar Jeetendra | November 17, 2020 No decision has been made, but the consensus among many experts in the U.S. and internationally is that health care workers should be first, said Sema Sgaier of the Surgo Foundation, a nonprofit group working on vaccine allocation difficulties. An expert panel advising the U.S. Centers for Disease Control and Prevention is also considering giving …
Antibiotics directed before age 2 are connected to ongoing conditions Kumar Jeetendra | November 16, 2020 In a retrospective case study, Mayo Clinic researchers have found that antibiotics administered to children younger than 2 are associated with several ongoing illnesses or ailments, which range from allergies to obesity. The findings appear in Mayo Clinic Proceedings. Using health record data from the Rochester Epidemiology Project, a population-based research cooperation in Minnesota and …
Bacteria use signaling particles to adjust their way of life to winning everyday environments Kumar Jeetendra | November 16, 2020 Bacteria are considered to be true experts in survival. Their rapid adaptive response to changing environmental conditions is based, among other things, on two rival signaling molecules. As the”Yin and Yang” of metabolic control they choose the lifestyle of bacteria, according to researchers in the University of Basel. The findings also play a role in …
China finds Covid on frozen beef, garbage from different nations Kumar Jeetendra | November 15, 2020 The eastern Chinese city of Jinan said it has discovered that the new coronavirus on beef and tripe, and on packaging for these products, from Brazil, New Zealand and Bolivia as China ramps up testing on frozen foods. The importers were a component of Guotai International Group and Shanghai Zhongli Development Trade, the Jinan Municipal …
Researchers translate why COVID-19 spares in kids Kumar Jeetendra | November 14, 2020 Researchers have found an integral aspect that might explain why the book coronavirus predominantly affects adults and older individuals while seeming to spare younger kids, an advance that may lead to the development of new treatment strategies for COVID-19. According to the researchers, including those from the Vanderbilt University Medical Center (VUMC) in the united …
Australian COVID-19 immunization:produces antibody response in early tests Kumar Jeetendra | November 13, 2020 Early testing of an expected COVID-19 vaccine developed by an Australian university and CSL has revealed it to be secure and produce an antibody response, Minister for Health Greg Hunt said on Friday. Pharmaceutical companies are rushing to create effective treatments for the illness amid a spike in COVID-19 cases that has killed over a …
Pioneering research detects Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) discovered in Prostate Cancer Kumar Jeetendra | November 12, 2020 Manchester, UK and Virginia, USA – 12th November 2020 – Life Science Newswire – Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides a …
Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology Kumar Jeetendra | November 12, 2020 HARRIETSHAM, UK – (November 12, 2020) – Life Science Newswire – Isohelix, a specialist provider of DNA and RNA sampling and purification products, announced that its state-of-the-art GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics, a leading healthcare technology company and high capacity molecular testing laboratory. The …
